Palisade Bio, Inc.
PALI· Nasdaq
Released Mar 30, 2012, during market hours
10-K filed Mar 30, 2012, 90 days after period end · 0001144204-12-018248
derived · Computed from the longer spans the company filed.
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Net Income | -$2.56M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Mar 30, 2012 · 90 d after period end